Acurx Pharmaceuticals, Inc. 10-K filing
Filed 2026-03-12 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001104659-26-027052
- Form type
- 10-K
- CIK
- 0001736243
- Primary document
- https://www.sec.gov/Archives/edgar/data/1736243/000110465926027052/acxp-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Acurx Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-8.1M | - | - |
| Net Income | $-8.0M | - | - |
| Eps Basic | -5.32 | - | - |
| Eps Diluted | -5.32 | - | - |
| Total Assets | $7.7M | - | - |
| Total Liabilities | $2.4M | - | - |
| Shareholders Equity | $5.3M | - | - |
| Operating Cash Flow | $-6.8M | - | - |